[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Adoptive Cell Therapy for Cancer Treatment Sales Market Report 2017

May 2014 | 108 pages | ID: GEB885E8B02EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global Adoptive Cell Therapy for Cancer Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Adoptive Cell Therapy for Cancer Treatment for these regions, from 2012 to 2022 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global Adoptive Cell Therapy for Cancer Treatment market competition by top manufacturers/players, with Adoptive Cell Therapy for Cancer Treatment sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Amgen
  • Merck
  • Eli Lilly
  • GlaxoSmithKline
  • Janssen
  • Genentech
  • Roche
  • Bristol-Myers Squibb
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
  • Surgery
  • Chemotherapy
  • Radiotherapy
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Adoptive Cell Therapy for Cancer Treatment for each application, including
  • Autologous adoptive T cell therapy
  • Allogeneic Adoptive T cell therapy
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Adoptive Cell Therapy for Cancer Treatment Sales Market Report 2017

1 ADOPTIVE CELL THERAPY FOR CANCER TREATMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Adoptive Cell Therapy for Cancer Treatment
1.2 Classification of Adoptive Cell Therapy for Cancer Treatment by Product Category
  1.2.1 Global Adoptive Cell Therapy for Cancer Treatment Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Adoptive Cell Therapy for Cancer Treatment Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Surgery
  1.2.4 Chemotherapy
  1.2.5 Radiotherapy
1.3 Global Adoptive Cell Therapy for Cancer Treatment Market by Application/End Users
  1.3.1 Global Adoptive Cell Therapy for Cancer Treatment Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Autologous adoptive T cell therapy
  1.3.3 Allogeneic Adoptive T cell therapy
1.4 Global Adoptive Cell Therapy for Cancer Treatment Market by Region
  1.4.1 Global Adoptive Cell Therapy for Cancer Treatment Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Adoptive Cell Therapy for Cancer Treatment Status and Prospect (2012-2022)
  1.4.3 China Adoptive Cell Therapy for Cancer Treatment Status and Prospect (2012-2022)
  1.4.4 Europe Adoptive Cell Therapy for Cancer Treatment Status and Prospect (2012-2022)
  1.4.5 Japan Adoptive Cell Therapy for Cancer Treatment Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Adoptive Cell Therapy for Cancer Treatment Status and Prospect (2012-2022)
  1.4.7 India Adoptive Cell Therapy for Cancer Treatment Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Adoptive Cell Therapy for Cancer Treatment (2012-2022)
  1.5.1 Global Adoptive Cell Therapy for Cancer Treatment Sales and Growth Rate (2012-2022)
  1.5.2 Global Adoptive Cell Therapy for Cancer Treatment Revenue and Growth Rate (2012-2022)

2 GLOBAL ADOPTIVE CELL THERAPY FOR CANCER TREATMENT COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Adoptive Cell Therapy for Cancer Treatment Market Competition by Players/Suppliers
  2.1.1 Global Adoptive Cell Therapy for Cancer Treatment Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Adoptive Cell Therapy for Cancer Treatment Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Adoptive Cell Therapy for Cancer Treatment (Volume and Value) by Type
  2.2.1 Global Adoptive Cell Therapy for Cancer Treatment Sales and Market Share by Type (2012-2017)
  2.2.2 Global Adoptive Cell Therapy for Cancer Treatment Revenue and Market Share by Type (2012-2017)
2.3 Global Adoptive Cell Therapy for Cancer Treatment (Volume and Value) by Region
  2.3.1 Global Adoptive Cell Therapy for Cancer Treatment Sales and Market Share by Region (2012-2017)
  2.3.2 Global Adoptive Cell Therapy for Cancer Treatment Revenue and Market Share by Region (2012-2017)
2.4 Global Adoptive Cell Therapy for Cancer Treatment (Volume) by Application

3 UNITED STATES ADOPTIVE CELL THERAPY FOR CANCER TREATMENT (VOLUME, VALUE AND SALES PRICE)

3.1 United States Adoptive Cell Therapy for Cancer Treatment Sales and Value (2012-2017)
  3.1.1 United States Adoptive Cell Therapy for Cancer Treatment Sales and Growth Rate (2012-2017)
  3.1.2 United States Adoptive Cell Therapy for Cancer Treatment Revenue and Growth Rate (2012-2017)
  3.1.3 United States Adoptive Cell Therapy for Cancer Treatment Sales Price Trend (2012-2017)
3.2 United States Adoptive Cell Therapy for Cancer Treatment Sales Volume and Market Share by Players
3.3 United States Adoptive Cell Therapy for Cancer Treatment Sales Volume and Market Share by Type
3.4 United States Adoptive Cell Therapy for Cancer Treatment Sales Volume and Market Share by Application

4 CHINA ADOPTIVE CELL THERAPY FOR CANCER TREATMENT (VOLUME, VALUE AND SALES PRICE)

4.1 China Adoptive Cell Therapy for Cancer Treatment Sales and Value (2012-2017)
  4.1.1 China Adoptive Cell Therapy for Cancer Treatment Sales and Growth Rate (2012-2017)
  4.1.2 China Adoptive Cell Therapy for Cancer Treatment Revenue and Growth Rate (2012-2017)
  4.1.3 China Adoptive Cell Therapy for Cancer Treatment Sales Price Trend (2012-2017)
4.2 China Adoptive Cell Therapy for Cancer Treatment Sales Volume and Market Share by Players
4.3 China Adoptive Cell Therapy for Cancer Treatment Sales Volume and Market Share by Type
4.4 China Adoptive Cell Therapy for Cancer Treatment Sales Volume and Market Share by Application

5 EUROPE ADOPTIVE CELL THERAPY FOR CANCER TREATMENT (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Adoptive Cell Therapy for Cancer Treatment Sales and Value (2012-2017)
  5.1.1 Europe Adoptive Cell Therapy for Cancer Treatment Sales and Growth Rate (2012-2017)
  5.1.2 Europe Adoptive Cell Therapy for Cancer Treatment Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Adoptive Cell Therapy for Cancer Treatment Sales Price Trend (2012-2017)
5.2 Europe Adoptive Cell Therapy for Cancer Treatment Sales Volume and Market Share by Players
5.3 Europe Adoptive Cell Therapy for Cancer Treatment Sales Volume and Market Share by Type
5.4 Europe Adoptive Cell Therapy for Cancer Treatment Sales Volume and Market Share by Application

6 JAPAN ADOPTIVE CELL THERAPY FOR CANCER TREATMENT (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Adoptive Cell Therapy for Cancer Treatment Sales and Value (2012-2017)
  6.1.1 Japan Adoptive Cell Therapy for Cancer Treatment Sales and Growth Rate (2012-2017)
  6.1.2 Japan Adoptive Cell Therapy for Cancer Treatment Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Adoptive Cell Therapy for Cancer Treatment Sales Price Trend (2012-2017)
6.2 Japan Adoptive Cell Therapy for Cancer Treatment Sales Volume and Market Share by Players
6.3 Japan Adoptive Cell Therapy for Cancer Treatment Sales Volume and Market Share by Type
6.4 Japan Adoptive Cell Therapy for Cancer Treatment Sales Volume and Market Share by Application

7 SOUTHEAST ASIA ADOPTIVE CELL THERAPY FOR CANCER TREATMENT (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Adoptive Cell Therapy for Cancer Treatment Sales and Value (2012-2017)
  7.1.1 Southeast Asia Adoptive Cell Therapy for Cancer Treatment Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Adoptive Cell Therapy for Cancer Treatment Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Adoptive Cell Therapy for Cancer Treatment Sales Price Trend (2012-2017)
7.2 Southeast Asia Adoptive Cell Therapy for Cancer Treatment Sales Volume and Market Share by Players
7.3 Southeast Asia Adoptive Cell Therapy for Cancer Treatment Sales Volume and Market Share by Type
7.4 Southeast Asia Adoptive Cell Therapy for Cancer Treatment Sales Volume and Market Share by Application

8 INDIA ADOPTIVE CELL THERAPY FOR CANCER TREATMENT (VOLUME, VALUE AND SALES PRICE)

8.1 India Adoptive Cell Therapy for Cancer Treatment Sales and Value (2012-2017)
  8.1.1 India Adoptive Cell Therapy for Cancer Treatment Sales and Growth Rate (2012-2017)
  8.1.2 India Adoptive Cell Therapy for Cancer Treatment Revenue and Growth Rate (2012-2017)
  8.1.3 India Adoptive Cell Therapy for Cancer Treatment Sales Price Trend (2012-2017)
8.2 India Adoptive Cell Therapy for Cancer Treatment Sales Volume and Market Share by Players
8.3 India Adoptive Cell Therapy for Cancer Treatment Sales Volume and Market Share by Type
8.4 India Adoptive Cell Therapy for Cancer Treatment Sales Volume and Market Share by Application

9 GLOBAL ADOPTIVE CELL THERAPY FOR CANCER TREATMENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Amgen
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Adoptive Cell Therapy for Cancer Treatment Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Amgen Adoptive Cell Therapy for Cancer Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Merck
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Adoptive Cell Therapy for Cancer Treatment Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Merck Adoptive Cell Therapy for Cancer Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Eli Lilly
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Adoptive Cell Therapy for Cancer Treatment Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Eli Lilly Adoptive Cell Therapy for Cancer Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 GlaxoSmithKline
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Adoptive Cell Therapy for Cancer Treatment Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 GlaxoSmithKline Adoptive Cell Therapy for Cancer Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Janssen
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Adoptive Cell Therapy for Cancer Treatment Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Janssen Adoptive Cell Therapy for Cancer Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Genentech
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Adoptive Cell Therapy for Cancer Treatment Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Genentech Adoptive Cell Therapy for Cancer Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Roche
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Adoptive Cell Therapy for Cancer Treatment Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Roche Adoptive Cell Therapy for Cancer Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Bristol-Myers Squibb
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Adoptive Cell Therapy for Cancer Treatment Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Bristol-Myers Squibb Adoptive Cell Therapy for Cancer Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview

10 ADOPTIVE CELL THERAPY FOR CANCER TREATMENT MAUFACTURING COST ANALYSIS

10.1 Adoptive Cell Therapy for Cancer Treatment Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Adoptive Cell Therapy for Cancer Treatment
10.3 Manufacturing Process Analysis of Adoptive Cell Therapy for Cancer Treatment

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Adoptive Cell Therapy for Cancer Treatment Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Adoptive Cell Therapy for Cancer Treatment Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL ADOPTIVE CELL THERAPY FOR CANCER TREATMENT MARKET FORECAST (2017-2022)

14.1 Global Adoptive Cell Therapy for Cancer Treatment Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Adoptive Cell Therapy for Cancer Treatment Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Adoptive Cell Therapy for Cancer Treatment Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Adoptive Cell Therapy for Cancer Treatment Price and Trend Forecast (2017-2022)
14.2 Global Adoptive Cell Therapy for Cancer Treatment Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Adoptive Cell Therapy for Cancer Treatment Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Adoptive Cell Therapy for Cancer Treatment Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Adoptive Cell Therapy for Cancer Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Adoptive Cell Therapy for Cancer Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Adoptive Cell Therapy for Cancer Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Adoptive Cell Therapy for Cancer Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Adoptive Cell Therapy for Cancer Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Adoptive Cell Therapy for Cancer Treatment Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Adoptive Cell Therapy for Cancer Treatment Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Adoptive Cell Therapy for Cancer Treatment Sales Forecast by Type (2017-2022)
  14.3.2 Global Adoptive Cell Therapy for Cancer Treatment Revenue Forecast by Type (2017-2022)
  14.3.3 Global Adoptive Cell Therapy for Cancer Treatment Price Forecast by Type (2017-2022)
14.4 Global Adoptive Cell Therapy for Cancer Treatment Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Adoptive Cell Therapy for Cancer Treatment
Figure Global Adoptive Cell Therapy for Cancer Treatment Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure Surgery Product Picture
Figure Chemotherapy Product Picture
Figure Radiotherapy Product Picture
Figure Global Adoptive Cell Therapy for Cancer Treatment Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of Adoptive Cell Therapy for Cancer Treatment by Application in 2016
Figure Autologous adoptive T cell therapy Examples
Figure Allogeneic Adoptive T cell therapy Examples
Figure Global Adoptive Cell Therapy for Cancer Treatment Market Size (Million USD) by Regions (2012-2022)
Figure United States Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) (2012-2017)
Table Global Adoptive Cell Therapy for Cancer Treatment Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global Adoptive Cell Therapy for Cancer Treatment Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Adoptive Cell Therapy for Cancer Treatment Sales Share by Players/Suppliers
Figure 2017 Adoptive Cell Therapy for Cancer Treatment Sales Share by Players/Suppliers
Figure Global Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Adoptive Cell Therapy for Cancer Treatment Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Adoptive Cell Therapy for Cancer Treatment Revenue Share by Players
Table 2017 Global Adoptive Cell Therapy for Cancer Treatment Revenue Share by Players
Table Global Adoptive Cell Therapy for Cancer Treatment Sales (K Units) and Market Share by Type (2012-2017)
Table Global Adoptive Cell Therapy for Cancer Treatment Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of Adoptive Cell Therapy for Cancer Treatment by Type (2012-2017)
Figure Global Adoptive Cell Therapy for Cancer Treatment Sales Growth Rate by Type (2012-2017)
Table Global Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Adoptive Cell Therapy for Cancer Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Adoptive Cell Therapy for Cancer Treatment by Type (2012-2017)
Figure Global Adoptive Cell Therapy for Cancer Treatment Revenue Growth Rate by Type (2012-2017)
Table Global Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global Adoptive Cell Therapy for Cancer Treatment Sales Share by Region (2012-2017)
Figure Sales Market Share of Adoptive Cell Therapy for Cancer Treatment by Region (2012-2017)
Figure Global Adoptive Cell Therapy for Cancer Treatment Sales Growth Rate by Region in 2016
Table Global Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Adoptive Cell Therapy for Cancer Treatment Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Adoptive Cell Therapy for Cancer Treatment by Region (2012-2017)
Figure Global Adoptive Cell Therapy for Cancer Treatment Revenue Growth Rate by Region in 2016
Table Global Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Adoptive Cell Therapy for Cancer Treatment Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Adoptive Cell Therapy for Cancer Treatment by Region (2012-2017)
Figure Global Adoptive Cell Therapy for Cancer Treatment Revenue Market Share by Region in 2016
Table Global Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global Adoptive Cell Therapy for Cancer Treatment Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Adoptive Cell Therapy for Cancer Treatment by Application (2012-2017)
Figure Global Adoptive Cell Therapy for Cancer Treatment Sales Market Share by Application (2012-2017)
Figure United States Adoptive Cell Therapy for Cancer Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure United States Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Adoptive Cell Therapy for Cancer Treatment Sales Price (USD/Unit) Trend (2012-2017)
Table United States Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) by Players (2012-2017)
Table United States Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Players (2012-2017)
Figure United States Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Players in 2016
Table United States Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) by Type (2012-2017)
Table United States Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Type (2012-2017)
Figure United States Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Type in 2016
Table United States Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) by Application (2012-2017)
Table United States Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Application (2012-2017)
Figure United States Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Application in 2016
Figure China Adoptive Cell Therapy for Cancer Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure China Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Adoptive Cell Therapy for Cancer Treatment Sales Price (USD/Unit) Trend (2012-2017)
Table China Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) by Players (2012-2017)
Table China Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Players (2012-2017)
Figure China Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Players in 2016
Table China Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) by Type (2012-2017)
Table China Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Type (2012-2017)
Figure China Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Type in 2016
Table China Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) by Application (2012-2017)
Table China Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Application (2012-2017)
Figure China Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Application in 2016
Figure Europe Adoptive Cell Therapy for Cancer Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Adoptive Cell Therapy for Cancer Treatment Sales Price (USD/Unit) Trend (2012-2017)
Table Europe Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) by Players (2012-2017)
Table Europe Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Players (2012-2017)
Figure Europe Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Players in 2016
Table Europe Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) by Type (2012-2017)
Table Europe Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Type (2012-2017)
Figure Europe Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Type in 2016
Table Europe Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) by Application (2012-2017)
Table Europe Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Application (2012-2017)
Figure Europe Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Application in 2016
Figure Japan Adoptive Cell Therapy for Cancer Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Adoptive Cell Therapy for Cancer Treatment Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) by Players (2012-2017)
Table Japan Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Players (2012-2017)
Figure Japan Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Players in 2016
Table Japan Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) by Type (2012-2017)
Table Japan Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Type (2012-2017)
Figure Japan Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Type in 2016
Table Japan Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) by Application (2012-2017)
Table Japan Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Application (2012-2017)
Figure Japan Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Application in 2016
Figure Southeast Asia Adoptive Cell Therapy for Cancer Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Adoptive Cell Therapy for Cancer Treatment Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Players in 2016
Table Southeast Asia Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Type in 2016
Table Southeast Asia Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Application in 2016
Figure India Adoptive Cell Therapy for Cancer Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure India Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Adoptive Cell Therapy for Cancer Treatment Sales Price (USD/Unit) Trend (2012-2017)
Table India Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) by Players (2012-2017)
Table India Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Players (2012-2017)
Figure India Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Players in 2016
Table India Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) by Type (2012-2017)
Table India Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Type (2012-2017)
Figure India Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Type in 2016
Table India Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) by Application (2012-2017)
Table India Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Application (2012-2017)
Figure India Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share by Application in 2016
Table Amgen Basic Information List
Table Amgen Adoptive Cell Therapy for Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Adoptive Cell Therapy for Cancer Treatment Sales Growth Rate (2012-2017)
Figure Amgen Adoptive Cell Therapy for Cancer Treatment Sales Global Market Share (2012-2017
Figure Amgen Adoptive Cell Therapy for Cancer Treatment Revenue Global Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Adoptive Cell Therapy for Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Adoptive Cell Therapy for Cancer Treatment Sales Growth Rate (2012-2017)
Figure Merck Adoptive Cell Therapy for Cancer Treatment Sales Global Market Share (2012-2017
Figure Merck Adoptive Cell Therapy for Cancer Treatment Revenue Global Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Adoptive Cell Therapy for Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Adoptive Cell Therapy for Cancer Treatment Sales Growth Rate (2012-2017)
Figure Eli Lilly Adoptive Cell Therapy for Cancer Treatment Sales Global Market Share (2012-2017
Figure Eli Lilly Adoptive Cell Therapy for Cancer Treatment Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Adoptive Cell Therapy for Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Adoptive Cell Therapy for Cancer Treatment Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Adoptive Cell Therapy for Cancer Treatment Sales Global Market Share (2012-2017
Figure GlaxoSmithKline Adoptive Cell Therapy for Cancer Treatment Revenue Global Market Share (2012-2017)
Table Janssen Basic Information List
Table Janssen Adoptive Cell Therapy for Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Janssen Adoptive Cell Therapy for Cancer Treatment Sales Growth Rate (2012-2017)
Figure Janssen Adoptive Cell Therapy for Cancer Treatment Sales Global Market Share (2012-2017
Figure Janssen Adoptive Cell Therapy for Cancer Treatment Revenue Global Market Share (2012-2017)
Table Genentech Basic Information List
Table Genentech Adoptive Cell Therapy for Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genentech Adoptive Cell Therapy for Cancer Treatment Sales Growth Rate (2012-2017)
Figure Genentech Adoptive Cell Therapy for Cancer Treatment Sales Global Market Share (2012-2017
Figure Genentech Adoptive Cell Therapy for Cancer Treatment Revenue Global Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Adoptive Cell Therapy for Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Adoptive Cell Therapy for Cancer Treatment Sales Growth Rate (2012-2017)
Figure Roche Adoptive Cell Therapy for Cancer Treatment Sales Global Market Share (2012-2017
Figure Roche Adoptive Cell Therapy for Cancer Treatment Revenue Global Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Adoptive Cell Therapy for Cancer Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Adoptive Cell Therapy for Cancer Treatment Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Adoptive Cell Therapy for Cancer Treatment Sales Global Market Share (2012-2017
Figure Bristol-Myers Squibb Adoptive Cell Therapy for Cancer Treatment Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Adoptive Cell Therapy for Cancer Treatment
Figure Manufacturing Process Analysis of Adoptive Cell Therapy for Cancer Treatment
Figure Adoptive Cell Therapy for Cancer Treatment Industrial Chain Analysis
Table Raw Materials Sources of Adoptive Cell Therapy for Cancer Treatment Major Players in 2016
Table Major Buyers of Adoptive Cell Therapy for Cancer Treatment
Table Distributors/Traders List
Figure Global Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Adoptive Cell Therapy for Cancer Treatment Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share Forecast by Regions in 2022
Table Global Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Adoptive Cell Therapy for Cancer Treatment Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Adoptive Cell Therapy for Cancer Treatment Revenue Market Share Forecast by Regions in 2022
Figure United States Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China Adoptive Cell Therapy for Cancer Treatment Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Adoptive Cell Therapy for Cancer Treatment Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Adoptive Cell Therapy for Cancer Treatment Sales (K Units) Forecast by Type (2017-2022)
Figure Global Adoptive Cell Therapy for Cancer Treatment Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Adoptive Cell Therapy for Cancer Treatment Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Adoptive Cell Therapy for Cancer Treatment Revenue Market Share Forecast by Type (2017-2022)
Table Global Adoptive Cell Therapy for Cancer Treatment Price (USD/Unit) Forecast by Type (2017-2022)
Table Global Adoptive Cell Therapy for Cancer Treatment Sales (K Units) Forecast by Application (2017-2022)
Figure Global Adoptive Cell Therapy for Cancer Treatment Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications